StockWatch
·
Biological Products, (No Diagnostic Substances)
Corporate ActionMay 18, 2026, 06:07 AM

Vaxart Details $115K Securities Offering Expenses, Lincoln Park Agreements

AI Summary

Vaxart, Inc. filed an S-1 registration statement detailing estimated expenses of $115,000 for the registration and sale of common stock, including $85,000 for legal fees and $20,500 for accounting fees. The filing also included new Purchase and Registration Rights Agreements with Lincoln Park, both dated April 16, 2026. Additionally, the company outlined its indemnification policy for directors and officers, noting the SEC's stance that indemnification for Securities Act liabilities is against public policy.

Key Highlights

  • Estimated total expenses for common stock registration and sale: $115,000.
  • SEC registration fee for the offering: $3,477.32.
  • Legal fees for the offering estimated at $85,000.
  • Accounting fees for the offering estimated at $20,500.
  • Entered Purchase Agreement with Lincoln Park dated April 16, 2026.
  • Entered Registration Rights Agreement with Lincoln Park dated April 16, 2026.
  • Details indemnification for directors and officers under Delaware law and bylaws.
  • SEC deems indemnification for Securities Act liabilities unenforceable.